On December 23, 2020, Aimed Alliance submitted a comment to the New York Department of Health on a proposed rule to regulate cannabidiol (CBD) products sold in the state. Aimed Alliance expressed concern that the proposed rule allows high concentrations of CBD in food and dietary supplement products (up to 25mg per food product and up to 3,000mg per dietary supplement) despite the U.S. Food and Drug Administration (FDA) stating that CBD food and dietary supplement products are currently illegal. At this time, there is no regulatory pathway for such products to ensure that they are both safe and effective. High concentrations of CBD could result in harm to some consumers, as the effects of CBD in high doses and in special populations remain unclear. States should wait for FDA guidance on appropriate concentration levels before allowing CBD products to reach consumers. Read the full proposed rule here and our comment here.